Hi Tech Pharmacal Co Inc (HITK) financial statements (2022 and earlier)

Company profile

Business Address 369 BAYVIEW AVENUE
AMITYVILLE, NY 11701
State of Incorp. NY
Fiscal Year End April 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

4/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments100,610
Cash and cash equivalents100,610
Receivables63,775
Inventory, net of allowances, customer advances and progress billings39,229
Inventory39,229
Other current assets3,622
Other undisclosed current assets12,321
Total current assets:219,557
Noncurrent Assets
Property, plant and equipment32,168
Intangible assets, net (including goodwill), including:40,887
Intangible assets, net (excluding goodwill)40,342
Other undisclosed intangible assets, net (including goodwill)545
Other noncurrent assets428
Other undisclosed noncurrent assets1,956
Total noncurrent assets:75,439
TOTAL ASSETS:294,996
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities27,754
Accounts payable9,768
Accrued liabilities13,637
Employee-related liabilities3,288
Taxes payable1,061
Debt355
Other undisclosed current liabilities15,787
Total current liabilities:43,896
Noncurrent Liabilities
Long-term debt and lease obligation888
Long-term debt, excluding current maturities888
Other undisclosed noncurrent liabilities4,844
Total noncurrent liabilities:5,732
Total liabilities:49,628
Stockholders' equity
Stockholders' equity attributable to parent245,368
Common stock161
Treasury stock, value(24,301)
Additional paid in capital101,203
Retained earnings168,305
Total stockholders' equity:245,368
TOTAL LIABILITIES AND EQUITY:294,996

Income statement (P&L) ($ in thousands)

4/30/2013
Revenues
(Revenue, Net)
232,384
Cost of revenue
(Cost of Goods and Services Sold)
(117,304)
Gross profit:115,080
Operating expenses(84,390)
Operating income:30,690
Nonoperating expense(92,207)
Interest and debt expense(541)
Other undisclosed income from continuing operations before equity method investments, income taxes84,931
Income from continuing operations before income taxes:22,873
Income tax expense(6,622)
Net income available to common stockholders, diluted:16,251

Comprehensive Income ($ in thousands)

4/30/2013
Net income:16,251
Comprehensive income, net of tax, attributable to parent:16,251

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: